These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12270614)

  • 1. Use of molecular topology for the prediction of physico-chemical, pharmacokinetic and toxicological properties of a group of antihistaminic drugs.
    Duart MJ; Antón-Fos GM; de Julian-Ortiz JV; Gozalbes R; Gálvez J; García-Domenech R
    Int J Pharm; 2002 Oct; 246(1-2):111-9. PubMed ID: 12270614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of a mathematical topological pattern for the prediction of antihistaminic activity.
    Duart MJ; García-Domenech R; Antón-Fos GM; Gálvez J
    J Comput Aided Mol Des; 2001 Jun; 15(6):561-72. PubMed ID: 11495227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topological models for prediction of physico-chemical, pharmacokinetic and toxicological properties of antihistaminic drugs using decision tree and moving average analysis.
    Dureja H; Gupta S; Madan AK
    Int J Comput Biol Drug Des; 2009; 2(4):353-70. PubMed ID: 20090176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of a mathematical topological pattern of antihistaminic activity for the selection of new drug candidates and pharmacology assays.
    Duart MJ; García-Domenech R; Galvez J; Aleman PA; Martín-Algarra RV; Antón-Fos GM
    J Med Chem; 2006 Jun; 49(12):3667-73. PubMed ID: 16759109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New potential antihistaminic compounds. Virtual combinatorial chemistry, computational screening, real synthesis, and pharmacological evaluation.
    Duart MJ; Antón-Fos GM; Alemán PA; Gay-Roig JB; González-Rosende ME; Gálvez J; García-Domenech R
    J Med Chem; 2005 Feb; 48(4):1260-4. PubMed ID: 15715494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
    Deschamps C; Dubruc C; Mentre F; Rosenzweig P
    Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico ligand based design of indolylpiperidinyl derivatives as novel histamine H(1) receptor antagonists.
    Paliwal S; Singh S; Pal M
    Drug Discov Ther; 2012 Apr; 6(2):69-77. PubMed ID: 22622016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR study on competition binding of rodenticides (PATs) to H(1) receptor in rat and guinea pig brain.
    Agrawal VK; Karmarkar S; Khadikar PV
    Bioorg Med Chem; 2002 Sep; 10(9):2913-8. PubMed ID: 12110312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of pharmacological properties of a group of hypolipaemic drugs by molecular topology.
    Cercós-del-Pozo RA; Pérez-Giménez F; Gálvez-Alvarez J; Salabert-Salvador MT; Garcia-March FJ; Antón-Fos GM
    J Pharm Pharmacol; 1996 Mar; 48(3):240-4. PubMed ID: 8737046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dependence of the absorption through the human oral mucosa of antihistaminic (H1) preparations on their physicochemical properties].
    Bender KI; Lutsevich AN
    Farmakol Toksikol; 1988; 51(1):75-9. PubMed ID: 2896132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of acute toxicity of organophosphorus pesticides using topological indices.
    García-Domenech R; Alarcón-Elbal P; Bolas G; Bueno-Marí R; Chordá-Olmos FA; Delacour SA; Mouriño MC; Vidal A; Gálvez J
    SAR QSAR Environ Res; 2007; 18(7-8):745-55. PubMed ID: 18038371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retention pharmacokinetic and pharmacodynamic parameter relationships of antihistamine drugs using biopartitioning micellar chromatography.
    Quiñones-Torrelo C; Sagrado S; Villanueva-Camañas RM; Medina-Hernández MJ
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 761(1):13-26. PubMed ID: 11585127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and stability study of chlorpheniramine maleate nasal gel.
    Soliman II; Soliman NA; Abdou EM
    Pharm Dev Technol; 2010; 15(5):484-91. PubMed ID: 20735301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nonsedative H1 antihistaminics].
    Blehová H; Metys J
    Cas Lek Cesk; 1991 May; 130(14):436-7. PubMed ID: 1676935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discovery of CCR3/H1 dual antagonists with reduced hERG risk.
    Bahl A; Barton P; Bowers K; Brough S; Evans R; Luckhurst CA; Mochel T; Perry MW; Rigby A; Riley RJ; Sanganee H; Sisson A; Springthorpe B
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6688-93. PubMed ID: 23031591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of pharmacological properties of a group of beta-blocker agents by molecular topology.
    Garcia-March FJ; Cercós-Del-Pozo RA; Pérez-Giménez F; Salabert-Salvador MT; Jaén-Oltra J; Antón-Fos GM
    J Pharm Pharmacol; 1995 Mar; 47(3):232-6. PubMed ID: 7602487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
    Kakiuchi M; Ohashi T; Musoh K; Kawamura K; Morikawa K; Kato H
    Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers.
    Devalia JL; De Vos C; Hanotte F; Baltes E
    Allergy; 2001 Jan; 56(1):50-7. PubMed ID: 11167352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine.
    Urien S; Tillement JP; Ganem B; Kuch MD
    Int J Clin Pharmacol Ther; 1999 Oct; 37(10):499-502. PubMed ID: 10543317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel selective H1-antihistamine with optimized pharmacokinetic properties for clinical evaluation in the treatment of insomnia.
    Moree WJ; Li BF; Zamani-Kord S; Yu J; Coon T; Huang C; Marinkovic D; Tucci FC; Malany S; Bradbury MJ; Hernandez LM; Wen J; Wang H; Hoare SR; Petroski RE; Jalali K; Yang C; Sacaan A; Madan A; Crowe PD; Beaton G
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5874-8. PubMed ID: 20800486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.